-
Litigation teaches Chinese valsartan maker the downside of U.S. market
fiercepharma
October 10, 2018
China’s Zhejiang Huahai Pharmaceutical for years enjoyed the upside of the U.S. pharmaceutical market, selling its valsartan API to drugmakers producing blood pressure meds for the market.
-
EU regulators blast China’s Zhejiang Huahai over valsartan API mess
fiercepharma
September 29, 2018
The European Medicines Agency has piled onto China’s Zhejiang Huahai, finding its manufacturing out of compliance for the valsartan API that has been recalled globally after being found to contain a suspected carcinogen.
-
US FDA inspects Lupin’s Tarapur API facility
financialexpress
September 04, 2018
Rules out presence of NDMA impurity in co’s Valsartan, Losartan and Irbesartan APIs
-
A Glimpse of Influences of Tariff Slapping on the Chinese Pharmaceutical Industry at the Sensitive Time of Sino-U.S. Trade Friction
Xiaoyaowan
April 23, 2018
News about the trade war between the U.S. and China recently has been stirring the market nerves.
-
Sterling Pharma Invests £6M To Expand Offerings
contractpharma
April 20, 2018
Sterling Pharma Solutions, a CDMO, is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
-
Hovione divestment marks its commitment to supplying highly specialized APIs
cphi-online
March 12, 2018
Portuguese company exits the large volume business of contrast media to concentrate on its CDMO business.
-
FDA warns API maker Daito Kasei Kogyo, bans some products
fiercepharma
February 05, 2018
An API maker in Osaka, Japan, whose slogan is "Happiness, Awe and Surprise" has joined a growing list of Japanese drugmakers to be criticized by the FDA in warning letters.
-
Winter is Coming! —Events of the Chinese API Industry in 2017
Caicai
January 12, 2018
Winter is Coming! This line of the Game of Thrones well-known in the world may be used to best describe the current situation of the Chinese API industry.
-
End of the Era of API Approval Numbers! DMF Filing System Starting to be Implemented Formally
Caicai
December 27, 2017
Do you know how diligent this administration of CFDA is?
-
Perrigo Secures API Divestiture for $110M
contractpharm
November 22, 2017
Perrigo has completed its $ 110 million divestment of its API business in Israel